These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3621169)

  • 1. Prognostic significance of prolactin receptors in human breast cancer.
    Bonneterre J; Peyrat JP; Beuscart R; Lefebvre J; Demaille A
    Cancer Res; 1987 Sep; 47(17):4724-8. PubMed ID: 3621169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer.
    Bonneterre J; Peyrat JP; Beuscart R; Demaille A
    Cancer Res; 1990 Nov; 50(21):6931-5. PubMed ID: 2170011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
    Ben-David M; Wittliff JL; Fekete M; Kadar T; Biran S; Schally AV
    Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer.
    Bonneterre J; Peyrat JP; Beuscart R; Demaille A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1331-6. PubMed ID: 3830215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between PRL levels and steroid receptors in breast cancer.
    Marugo M; Fazzuoli L; Bernasconi D; Berta S; Giordano G
    Anticancer Res; 1988; 8(4):819-23. PubMed ID: 3178171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
    Leroy-Martin B; Peyrat JP
    Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with prognosis in human breast cancer. III. Estradiol receptors and short term relapse.
    Pascual MR; Macías A; Moreno L; Lage A
    Neoplasma; 1983; 30(5):589-92. PubMed ID: 6656962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between prognosis and hormone receptors in women with breast cancer.
    Papatestas AE; Miller SR; Pertsemlidis D; Fagerstrom R; Lesnick G; Aufses AH
    Cancer Detect Prev; 1986; 9(3-4):303-10. PubMed ID: 3742506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
    Derin D; Eralp Y; Ozluk Y; Yavuz E; Guney N; Saip P; Igci A; Ozmen V; Kücücük S; Aslay I; Aydiner A; Topuz E
    Cancer Invest; 2008 Aug; 26(7):671-9. PubMed ID: 18608215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
    Foekens JA; Peters HA; Look MP; Portengen H; Schmitt M; Kramer MD; Brünner N; Jänicke F; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten WL; Klijn JG
    Cancer Res; 2000 Feb; 60(3):636-43. PubMed ID: 10676647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
    Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.
    Liu ZB; Liu GY; Yang WT; Di GH; Lu JS; Shen KW; Shen ZZ; Shao ZM; Wu J
    Oncol Rep; 2008 Oct; 20(4):987-94. PubMed ID: 18813844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tree-based model for breast cancer prognostication.
    Banerjee M; George J; Song EY; Roy A; Hryniuk W
    J Clin Oncol; 2004 Jul; 22(13):2567-75. PubMed ID: 15226324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.